Close

Titan Pharma (TTNP) Granted European Medicines Agency Marketing Authorization Application For Probuphine

November 27, 2017 7:01 AM EST Send to a Friend
Titan Pharmaceuticals, Inc. (NASDAQ: TTNP) today announced that the European Medicines Agency has accepted for review its Marketing Authorization ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login